Flagship Harbor Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$10.2K 1166
2025
Q4
$10.2K Buy
+100
New +$8.03K ﹤0.01% 1502
2020
Q4
Sell
-1,128
Closed -$114K 907
2020
Q3
$114K Sell
1,128
-117
-9% -$10.1K 0.02% 616
2020
Q2
$108K Hold
1,245
0.02% 633
2020
Q1
$72K Buy
1,245
+352
+39% +$28.6K 0.01% 653
2019
Q4
$83K Sell
893
-147
-14% -$12.9K 0.01% 662
2019
Q3
$93K Buy
1,040
+923
+789% +$105K 0.02% 603
2019
Q2
$13K Buy
117
+17
+17% +$1.71K ﹤0.01% 1205
2019
Q1
$8K Hold
100
﹤0.01% 1352
2018
Q4
$6K Hold
100
﹤0.01% 1386
2018
Q3
$8K Hold
100
﹤0.01% 1515
2018
Q2
$5K Buy
+100
New +$5.38K ﹤0.01% 1627

Other funds holding EXAS

Flagship Harbor Advisors's EXAS Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 100 shares — an estimated $10.2K sold.

Flagship Harbor Advisors first reported a position in EXAS in Q2 2018 and held it in 11 quarters. The position peaked at $114K in Q3 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 100 Exact Sciences shares in Q1 2026, an estimated $10.2K.
  • Flagship Harbor Advisors first reported a position in Exact Sciences in Q2 2018 and held it in 11 quarters.
  • Flagship Harbor Advisors's Exact Sciences position peaked at $114K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.